References
On the Science of Essential Nutrients

Bliznakov, E.G. (1973). Effect of stimulation of the host defense system by coenzyme Q10 on dibenzpyrene-induced tumors and infection with Friend leukemia virus in mice. Proc. Natl. Acad. Sci. USA 70, 390-4.

Cathcart, R.F. (1980). The method for determining proper doses of vitamin C for the treatment of disease by titrating to bowel tolerance. Australasian Nurses J. 9(4), 9-13.

Cathcart, R.F. (1981). Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy. Medical Hypotheses, 7, 1359-76. (http://www.orthomed.com)

Cathcart, R.F. (1984). Vitamin C in the treatment of acquired immune deficiency syndrome (AIDS). Medical Hypotheses, 14(4), 423-33.

Cilento, P. (1973). The truth about vitamin E.Woman's Day, 12 November.

Chakrabarti, B. and Bannerjee, S. (1955). Dehydroascorbic acid level in blood of patients suffering from various infectious diseases. Proc. Soc. Exper. Biol. Med. 88, 581-3.

Chatterjee, I.B. and Bannerjee A. (1979). Estimation of dehydroascorbic acid in blood of diabetic patients. Anal. Biochem. 98, 368-74.

Cooper, M.R., McCall, C.E. and DeChatelet, L.R. (1971). Stimulation of leukocyte hexose monophosphate shunt activity by ascorbic acid. Infect Immun, 3, 851-3.

Cousins, L. (1983). Congenital anomalies among infants of diabetic mothers: Etiology, prevention, prenatal diagnosis. Am. J. Obstet. Gynecol. 147(3), 333-8.

Denson, K.W. and Bowers, E.F. (1961). The determination of ascorbic acid in white blood cells. Clin Sci, 21, 157-62.

Ely, J.T.A. (1981) Hyperglycemia and major congenital anomalies, New Engl. J. Med., 305(14), 833.

Ely, J.T.A. (1996). Glycemic modulation of tumor tolerance. J. Orthomolecular Med. 11(1), 23-34.

Ely, J.T.A. (1999). Ascorbic acid and some other modern analogs of the germ theory. J. Orthomolecular Med. 14(3),143-56.

Ely, J.T.A., Fudenberg, H.H., Bliznakov, E.G., Branch, J.D. (1998). Hemorrhagic Stroke in Human Pretreated with Coenzyme Q10: Exceptional Recovery as Seen in Animal Models. J. Orthomolecular Med. 13(2), 105-109.

Ely JTA, Fudenberg HH, Muirhead RJ, LaMarche MG, Krone CA, Buscher D, Stern EA. (1999). Urine mercury in micromercurialism: bimodal distribution and diagnostic implications. Bull Environ Contam Toxicol. 63(5):553-59.

Ely JTA, Krone CA. (2000). A brief update on ubiquinone (Coenzyme Q10) J Orthomolecular Med 15(2):63-68.

Esterbauer, H., Dieber-Rothender, M. and Striegl, G. (1991). Role of vitamin E in preventing oxidation of low-density lipoprotein. Am. J. Clin. Nutr. 53, 314s-21s.

Gey, K.F., Puska, P., Jordan, P. and Moser, U. (1991). Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am. J. Clin. Nutr. 53, 326s-34s.

Hamel, E.E., Santisteban, G.A., Ely, J.T.A. and Read, D.H. (1986). Hyperglycemia and reproductive defects in non-diabetic gravidas: a mouse model test of a new theory. Life Sci. 39, 1425-8.

Harman D: Prolongation of life: role of free radical reactions in aging. J Am Geriatr Soc. 1969; Aug; 17(8): 721-35.

Harman D. (1969). Prolongation of life: role of free radical reactions in aging. J Am Geriatr Soc.17(8): 721-35.

Harman D. (1981). The aging process. Proc Natl Acad Sci U S A. 78(11): 7124-8.

Harman D. (1972). The biological clock: The mitochondria? J Am Geriatr Soc. 20(4):145-47.

Harman D. (2001) Aging: Overview. Ann NY Acad Sci 928:1-21.

Hume, R., Weyers, W., Rowan, T., Reid, D.S., Hillis, W.S. (1972). Leucocyte ascorbic acid levels after acute myocardial infarction. Brit. Heart J. 34, 238-43.

Klenner, F.R. (1949). The treatment of poliomyelitis and other virus diseases with vitamin C. Southern Med. Surg. 111, 209-14.

Klenner, F.R. (1971). Observations on the dose and administration of ascorbic acid when employed beyond the range of a vitamin in human pathology. J. Appl. Nutr. 23, 61-88. (see http://www.orthomed.com)

Klenner, F.R. (1974). Significance of high daily intake of ascorbic acid in preventive medicine. J. Prev. Med. Spring, 45-69. (see http://www.orthomed.com)

Koroljow, S. (1962). Insulin coma therapy. Psychiatric Quarterly 36, 261-70.

Krone CA, Elmer GW, Ely JTA, Fudenberg HH, Thoreson J. (2001). Does gastrointestinal Candida albicans prevent ubiquinone absorption? Med Hypoth. 57(5):570-72.

Langsjoen, P.H. (1995). Introduction to Coenzyme Q10. On web site http://faculty.washington.edu/ely

Langsjoen PH, Langsjoen AM. (1999) Overview of the use of CoQ10 in cardiovascular disease. BioFactors 9:273-84. (can be found at http://wwwcsi.unian.it/coenzymeQ/overview.html).

Lewin, S. (1976). Vitamin C: Its Molecular Biology and Medical Potential. New York, Academic Press, p.109.

Marshall, J.C., Christou, N.V., Horn, R., Meakins, J.L. (1988). The microbiology of multiple organ failure. The proximal gastrointestinal tract as an occult reservoir of pathogens. Arch. Surg .123, 309-15.

Pauling, L.J. (1987). How to live longer and feel better. Avon Books, New York, pp.413.
Relman, A.S., (1992). Reforming our health care system: A physician's perspective. Phi Beta Kappa Key Reporter 58(Autumn), 1-5.

Santisteban, G.A., Ely, J.T.A., Hamel, E.E., Read, D.H. and Kozawa, S.M. (1985). Glycemic modulation of tumor tolerance in a mouse model of breast cancer. Biochem. Biophys. Res. Commun. 132(3), 1174-9.

Shute, W.E. (1975). Dr Wilfred Shute's complete updated vitamin E book. Keats Publish., New Canaan CT, pp. 255.

Sirsi, M. (1952). Antimicrobial action of vitamin C on M. tuberculosis and some other pathogenic organisms. Indian J. Med. Sci. (Bombay) 6, 252-5.

Stone, I. (1972). The Healing Factor. Grosset & Dunlap, New York, pp. 258.

Watson, T.J. Jr. (1973). Health Service. J. Am. Soc. Prev. Dent. 3(1), 12-3.



On the Science of Essential Nutrients

Updated September 2002